Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA product warning

This article was originally published in The Tan Sheet

Executive Summary

Ingredients in San Rafael, Calif.-based MOM Enterprises' Mommy's Bliss Nipple Cream - chlorphenesin and phenoxyethanol - are potentially harmful to nursing infants, causing respiratory distress or vomiting and diarrhea, FDA says in a consumer warning May 23. Despite the potential danger for infants, the product's labeling states there is no need to remove the cream before nursing, FDA says. Chlorphenesin can also harm the mother by causing the skin condition dermatitis. The agency says MOM Enterprises has discontinued marketing of the product, and the agency has not yet received any adverse event reports concerning infants...

Ingredients in San Rafael, Calif.-based MOM Enterprises' Mommy's Bliss Nipple Cream - chlorphenesin and phenoxyethanol - are potentially harmful to nursing infants, causing respiratory distress or vomiting and diarrhea, FDA says in a consumer warning May 23. Despite the potential danger for infants, the product's labeling states there is no need to remove the cream before nursing, FDA says. Chlorphenesin can also harm the mother by causing the skin condition dermatitis. The agency says MOM Enterprises has discontinued marketing of the product, and the agency has not yet received any adverse event reports concerning infants....

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS101716

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel